<rss version="2.0"><channel><title>Yahoo! Finance: NVC.TO News</title><copyright>Copyright (c) 2017 Yahoo! Inc. All rights reserved.</copyright><link>http://finance.yahoo.com/q/h?s=nvc.to</link><description>Latest Financial News for NEOVASC INC</description><language>en-US</language><lastBuildDate>Fri, 13 Jan 2017 13:15:00 GMT</lastBuildDate><image><url>http://l.yimg.com/a/i/brand/purplelogo/uh/us/fin.gif</url><title>Yahoo! Finance: NVC.TO News</title><link>http://finance.yahoo.com/q/h?s=nvc.to</link><width>144</width><height>45</height></image><item><title>Research Reports Initiated on Healthcare Stocks Acerus Pharmaceuticals, Neovasc, Nuvo Pharmaceuticals, and Titan Medical</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/research-reports-initiated-healthcare-stocks-131500982.html</link><description /><guid isPermaLink="false">yahoo_finance/3441741529</guid><pubDate>Fri, 13 Jan 2017 13:15:00 GMT</pubDate></item><item><title>IIROC Trade Resumption - NVC</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/iiroc-trade-resumption-nvc-174700479.html</link><description /><guid isPermaLink="false">yahoo_finance/1546810348</guid><pubDate>Fri, 23 Dec 2016 17:47:00 GMT</pubDate></item><item><title>IIROC Trade Resumption - NVC</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/iiroc-trade-resumption-nvc-174700197.html</link><description /><guid isPermaLink="false">yahoo_finance/4289301023</guid><pubDate>Fri, 23 Dec 2016 17:47:00 GMT</pubDate></item><item><title>Neovasc Announces Update in Litigation with CardiAQ</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/neovasc-announces-litigation-cardiaq-172800725.html</link><description>[CNW Group] - Neovasc Announces Update in Litigation with CardiAQ</description><guid isPermaLink="false">yahoo_finance/3482770628</guid><pubDate>Fri, 23 Dec 2016 17:28:00 GMT</pubDate></item><item><title>Neovasc Announces Update in Litigation with CardiAQ</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/neovasc-announces-litigation-cardiaq-172800504.html</link><description>[PR Newswire] - VANCOUVER, Dec. 23, 2016 /PRNewswire/ - Neovasc Inc. ("Neovasc" or the "Company") (NVCN) (NVC.TO) reported today that the United States District Court for the District of Massachusetts has granted a stay of judgment pending the completion of its appeal.</description><guid isPermaLink="false">yahoo_finance/73795423</guid><pubDate>Fri, 23 Dec 2016 17:28:00 GMT</pubDate></item><item><title>IIROC Trading Halt - NVC</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/iiroc-trading-halt-nvc-172000178.html</link><description /><guid isPermaLink="false">yahoo_finance/1289448709</guid><pubDate>Fri, 23 Dec 2016 17:20:00 GMT</pubDate></item><item><title>IIROC Trading Halt - NVC</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/iiroc-trading-halt-nvc-172000725.html</link><description /><guid isPermaLink="false">yahoo_finance/3602132033</guid><pubDate>Fri, 23 Dec 2016 17:20:00 GMT</pubDate></item><item><title>IIROC Trade Resumption - NVC</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/iiroc-trade-resumption-nvc-171000225.html</link><description /><guid isPermaLink="false">yahoo_finance/3524250687</guid><pubDate>Tue, 20 Dec 2016 17:10:00 GMT</pubDate></item><item><title>IIROC Trade Resumption - NVC</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/iiroc-trade-resumption-nvc-171000114.html</link><description /><guid isPermaLink="false">yahoo_finance/1649580690</guid><pubDate>Tue, 20 Dec 2016 17:10:00 GMT</pubDate></item><item><title>IIROC Trading Halt - NVC</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/iiroc-trading-halt-nvc-165900327.html</link><description /><guid isPermaLink="false">yahoo_finance/1011695058</guid><pubDate>Tue, 20 Dec 2016 16:59:00 GMT</pubDate></item><item><title>IIROC Trading Halt - NVC</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/iiroc-trading-halt-nvc-165900712.html</link><description /><guid isPermaLink="false">yahoo_finance/1755169646</guid><pubDate>Tue, 20 Dec 2016 16:59:00 GMT</pubDate></item><item><title>Neovasc Regains Compliance with NASDAQ Listing Requirements</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/neovasc-regains-compliance-nasdaq-listing-185600507.html</link><description>[PR Newswire] - VANCOUVER, Dec. 19, 2016 /PRNewswire/ - Neovasc Inc. ("Neovasc" or the "Company") (NVCN) (NVC.TO) announced today that the Company has regained compliance with the listing requirements of The NASDAQ Stock Market LLC ("Nasdaq"). As previously reported, on July 5, 2016, Neovasc received a letter from Nasdaq notifying the Company that it was not in compliance with the minimum bid price requirement set forth in the Nasdaq Rules for continued listing on The Nasdaq Capital Market.</description><guid isPermaLink="false">yahoo_finance/3958415822</guid><pubDate>Mon, 19 Dec 2016 18:56:00 GMT</pubDate></item><item><title>Neovasc Regains Compliance with NASDAQ Listing Requirements</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/neovasc-regains-compliance-nasdaq-listing-185600277.html</link><description>[CNW Group] - Neovasc Regains Compliance with NASDAQ Listing Requirements</description><guid isPermaLink="false">yahoo_finance/3464058728</guid><pubDate>Mon, 19 Dec 2016 18:56:00 GMT</pubDate></item><item><title>Boston Scientific Acquires Neovasc to Boost Heart Business</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/boston-scientific-acquires-neovasc-boost-132401627.html</link><description /><guid isPermaLink="false">yahoo_finance/2739859664</guid><pubDate>Wed, 14 Dec 2016 13:24:01 GMT</pubDate></item><item><title>Boston Scientific Closes Acquisition of Advanced Biological Tissue Capabilities and Acquires Common Shares of Neovasc, Inc.</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/boston-scientific-closes-acquisition-advanced-120000813.html</link><description>[PR Newswire] - MARLBOROUGH, Mass., Dec. 13, 2016 /PRNewswire/ -- Boston Scientific Corporation (BSX) today announced the close of its acquisition of certain manufacturing assets and capabilities of the Neovasc, Inc., (NVCN) (NVC.TO) advanced biological tissue business. The two organizations announced a definitive agreement on December 2, 2016 for Boston Scientific to acquire the advanced biologic tissue capabilities and make a 15% equity investment in Neovasc, for a total of $75 million in cash. The common shares were acquired for investment purposes.</description><guid isPermaLink="false">yahoo_finance/3473028618</guid><pubDate>Tue, 13 Dec 2016 12:00:00 GMT</pubDate></item><item><title>Neovasc and Boston Scientific Close US$75 Million Agreement</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/neovasc-boston-scientific-close-us-120000034.html</link><description>[CNW Group] - Neovasc and Boston Scientific Close US$75 Million Agreement</description><guid isPermaLink="false">yahoo_finance/2547157648</guid><pubDate>Tue, 13 Dec 2016 12:00:00 GMT</pubDate></item><item><title>Neovasc and Boston Scientific Close US$75 Million Agreement</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/neovasc-boston-scientific-close-us-120000107.html</link><description>[PR Newswire] - VANCOUVER, Dec. 13, 2016 /PRNewswire/ - Neovasc Inc. ("Neovasc" or the "Company") (NVCN) (NVC.TO) today announced the close of its transaction with Boston Scientific Corporation (BSX). The two organizations announced a definitive agreement on December 2, 2016 for Boston Scientific to acquire Neovasc's advanced biologic tissue capabilities and certain manufacturing assets and make a 15% equity investment in Neovasc, for a total of US$75 million in cash. Under the terms of the asset purchase agreement Neovasc has been granted a license to the purchased assets and access to the sold facilities to allow it to continue its tissue and valve assembly activities for its remaining customers, and continue its own tissue-related programs, including advancing its mitral bioprosthesis valve Tiara&#8482; through its clinical and regulatory pathways.</description><guid isPermaLink="false">yahoo_finance/2210013257</guid><pubDate>Tue, 13 Dec 2016 12:00:00 GMT</pubDate></item><item><title>Neovasc, Inc. :NVC-CA: Earnings Analysis: Q3, 2016 By the Numbers : December 9, 2016</title><link>http://us.rd.yahoo.com/finance/external/xcapitalcube/rss/SIG=13og95ro6/*http://www.capitalcube.com/blog/index.php/neovasc-inc-nvc-ca-earnings-analysis-q3-2016-by-the-numbers-december-9-2016/</link><description /><guid isPermaLink="false">yahoo_finance/4168946095</guid><pubDate>Fri, 09 Dec 2016 13:17:47 GMT</pubDate></item><item><title>Neovasc Provides Update on its Tiara&#8482; Mitral Valve Clinical Program</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/neovasc-provides-tiara-mitral-valve-120000677.html</link><description>[CNW Group] - Neovasc Provides Update on its Tiara&#8482; Mitral Valve Clinical Program</description><guid isPermaLink="false">yahoo_finance/916082687</guid><pubDate>Tue, 06 Dec 2016 12:00:00 GMT</pubDate></item><item><title>Neovasc Provides Update on its Tiara&#8482; Mitral Valve Clinical Program</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/neovasc-provides-tiara-mitral-valve-120000310.html</link><description>[PR Newswire] - VANCOUVER, Dec. 6, 2016 /PRNewswire/ - Neovasc Inc. ("Neovasc" or the "Company") (NVCN) (NVC.TO) today provided an update on the clinical experience with its Tiara&#8482; transcatheter mitral valve. Tiara&#8482; is a novel transcatheter device designed to treat mitral regurgitation (MR), a condition that is often severe and can lead to heart failure and death. There have been no reported adverse events related to the valve performance. There have been no frame fractures, or any device performance issues observed with the Tiara&#8482; in any patient follow-up.</description><guid isPermaLink="false">yahoo_finance/548292199</guid><pubDate>Tue, 06 Dec 2016 12:00:00 GMT</pubDate></item></channel></rss>